Chemoinformaics analysis of Propionic acid, 2-mercapto-, allyl ester
| Molecular Weight | 146.211 | nRot | 3 |
| Heavy Atom Molecular Weight | 136.131 | nRig | 2 |
| Exact Molecular Weight | 146.04 | nRing | 0 |
| Solubility: LogS | -1.537 | nHRing | 0 |
| Solubility: LogP | 1.642 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 21.1919 |
| nHD | 1 | BPOL | 15.0961 |
| QED | 0.366 |
| Synth | 3.394 |
| Natural Product Likeliness | -0.126 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.463 |
| MDCK | 0.0000435 |
| BBB | 0.874 |
| PPB | 0.664232 |
| VDSS | 0.899 |
| FU | 0.469966 |
| CYP1A2-inh | 0.23 |
| CYP1A2-sub | 0.39 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.48 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.351 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.352 |
| CYP3a4-inh | 0.025 |
| CYP3a4-sub | 0.271 |
| CL | 9.56 |
| T12 | 0.822 |
| hERG | 0.016 |
| Ames | 0.131 |
| ROA | 0.677 |
| SkinSen | 0.35 |
| Carcinogencity | 0.323 |
| EI | 0.363 |
| Respiratory | 0.207 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.974242 |